Research Article

Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model

Figure 5

Subchronic treatment with fenofibrate (F), metformin (M), and their combination prevented the decreased expression of PPARα in diabetic-ischemia/reperfusion (DBI/R) conditions. (a) Representative immunoblot and (b) PPARα expression in ischemic left ventricle area ( rats/group). versus control-sham- (CTSH-) Vehicle and versus DBI/R-Vehicle two-way ANOVA followed by Duncan’s post hoc test. Data are presented as means ± SEM.
(a)
(b)